Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial
Rarely, allergic reactions can occur, which is why a health assessment before starting treatment is so important
If you miss two or more consecutive doses: This is where you need to talk to your prescribing physician
Many patients also experience nutritional gaps that can impact their comfort and recovery
Personalized Strategies for Sustainable Weight Loss Success in weight loss requires more than a one-size-fits-all approach
Wilbourn, International Agency for Research on Cancer, Lyons, France ------------------------------------------------------------------- a IPCS Consultant